Nuwellis, Inc. (NUWE)
USD 0.84
(-12.5%)
USD 0.84
(-12.5%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 9.77 Million USD | -60.4% |
| 2022 | 24.67 Million USD | -18.88% |
| 2021 | 30.41 Million USD | 51.99% |
| 2020 | 20.01 Million USD | 257.23% |
| 2019 | 5.6 Million USD | -36.17% |
| 2018 | 8.77 Million USD | -52.45% |
| 2017 | 18.45 Million USD | 147.02% |
| 2016 | 7.47 Million USD | -69.59% |
| 2015 | 24.57 Million USD | -24.1% |
| 2014 | 32.37 Million USD | -41.39% |
| 2013 | 55.23 Million USD | 267.32% |
| 2012 | 15.03 Million USD | 102.34% |
| 2011 | 7.43 Million USD | 66.06% |
| 2010 | 4.47 Million USD | 125.67% |
| 2009 | 1.98 Million USD | -79.64% |
| 2008 | 9.73 Million USD | 36.98% |
| 2007 | 7.1 Million USD | 49.65% |
| 2006 | 4.75 Million USD | -37.83% |
| 2005 | 7.64 Million USD | 442.13% |
| 2004 | 1.4 Million USD | 9.8% |
| 2003 | 1.28 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 6.18 Million USD | -7.1% |
| 2024 Q1 | 6.66 Million USD | -31.81% |
| 2023 Q2 | 15.55 Million USD | -15.83% |
| 2023 Q4 | 9.77 Million USD | -14.54% |
| 2023 Q3 | 11.43 Million USD | -26.5% |
| 2023 FY | 9.77 Million USD | -60.4% |
| 2023 Q1 | 18.47 Million USD | -25.1% |
| 2022 FY | 24.67 Million USD | -18.88% |
| 2022 Q4 | 24.67 Million USD | 33.82% |
| 2022 Q2 | 21.99 Million USD | -15.74% |
| 2022 Q1 | 26.1 Million USD | -14.17% |
| 2022 Q3 | 18.43 Million USD | -16.19% |
| 2021 Q2 | 29.64 Million USD | -11.69% |
| 2021 Q1 | 33.56 Million USD | 67.71% |
| 2021 FY | 30.41 Million USD | 51.99% |
| 2021 Q4 | 30.41 Million USD | -10.79% |
| 2021 Q3 | 34.09 Million USD | 15.03% |
| 2020 Q4 | 20.01 Million USD | -15.63% |
| 2020 Q1 | 10.04 Million USD | 79.35% |
| 2020 FY | 20.01 Million USD | 257.23% |
| 2020 Q2 | 13.14 Million USD | 30.82% |
| 2020 Q3 | 23.71 Million USD | 80.47% |
| 2019 Q2 | 11.42 Million USD | -25.61% |
| 2019 Q3 | 7.58 Million USD | -33.64% |
| 2019 Q4 | 5.6 Million USD | -26.13% |
| 2019 FY | 5.6 Million USD | -36.17% |
| 2019 Q1 | 15.36 Million USD | 75.06% |
| 2018 FY | 8.77 Million USD | -52.45% |
| 2018 Q4 | 8.77 Million USD | -25.57% |
| 2018 Q3 | 11.79 Million USD | 7.8% |
| 2018 Q2 | 10.93 Million USD | -24.1% |
| 2018 Q1 | 14.41 Million USD | -21.91% |
| 2017 Q4 | 18.45 Million USD | 97.59% |
| 2017 Q3 | 9.34 Million USD | -20.88% |
| 2017 FY | 18.45 Million USD | 147.02% |
| 2017 Q2 | 11.8 Million USD | 50.92% |
| 2017 Q1 | 7.82 Million USD | 4.7% |
| 2016 Q4 | 7.47 Million USD | 12.84% |
| 2016 FY | 7.47 Million USD | -69.59% |
| 2016 Q2 | 12.99 Million USD | -26.89% |
| 2016 Q1 | 17.77 Million USD | -27.64% |
| 2016 Q3 | 6.62 Million USD | -49.06% |
| 2015 Q4 | 24.57 Million USD | -16.33% |
| 2015 FY | 24.57 Million USD | -24.1% |
| 2015 Q2 | 34.91 Million USD | -10.01% |
| 2015 Q3 | 29.36 Million USD | -15.89% |
| 2015 Q1 | 38.79 Million USD | 19.84% |
| 2014 Q1 | 48.87 Million USD | -11.5% |
| 2014 FY | 32.37 Million USD | -41.39% |
| 2014 Q4 | 32.37 Million USD | -14.34% |
| 2014 Q3 | 37.79 Million USD | -12.87% |
| 2014 Q2 | 43.37 Million USD | -11.26% |
| 2013 Q3 | 60.8 Million USD | 168.55% |
| 2013 Q2 | 22.64 Million USD | 89.93% |
| 2013 Q1 | 11.92 Million USD | -20.71% |
| 2013 FY | 55.23 Million USD | 267.32% |
| 2013 Q4 | 55.23 Million USD | -9.17% |
| 2012 Q4 | 15.03 Million USD | -19.19% |
| 2012 FY | 15.03 Million USD | 102.34% |
| 2012 Q2 | 2.9 Million USD | -41.84% |
| 2012 Q1 | 4.99 Million USD | -32.73% |
| 2012 Q3 | 18.6 Million USD | 540.04% |
| 2011 Q4 | 7.43 Million USD | -30.3% |
| 2011 Q2 | 6.83 Million USD | 0.0% |
| 2011 FY | 7.43 Million USD | 66.06% |
| 2011 Q3 | 10.66 Million USD | 56.0% |
| 2010 FY | 4.47 Million USD | 125.67% |
| 2010 Q4 | 12.72 Million USD | 0.0% |
| 2010 Q2 | 4.47 Million USD | 0.0% |
| 2009 Q4 | 7.42 Million USD | 0.0% |
| 2009 FY | 1.98 Million USD | -79.64% |
| 2009 Q2 | 1.98 Million USD | 0.0% |
| 2008 Q2 | 9.73 Million USD | 0.0% |
| 2008 Q4 | 4.33 Million USD | 0.0% |
| 2008 FY | 9.73 Million USD | 36.98% |
| 2007 FY | 7.1 Million USD | 49.65% |
| 2007 Q2 | 7.1 Million USD | 0.0% |
| 2007 Q4 | 7.78 Million USD | 0.0% |
| 2006 Q4 | 12.96 Million USD | 0.0% |
| 2006 Q2 | 4.75 Million USD | 0.0% |
| 2006 FY | 4.75 Million USD | -37.83% |
| 2005 FY | 7.64 Million USD | 442.13% |
| 2005 Q4 | 6.56 Million USD | 0.0% |
| 2005 Q2 | 7.64 Million USD | 0.0% |
| 2004 FY | 1.4 Million USD | 9.8% |
| 2004 Q4 | 9.8 Million USD | 0.0% |
| 2004 Q2 | 1.4 Million USD | 0.0% |
| 2003 FY | 1.28 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 68.852% |
| BrainsWay Ltd. | 62.97 Million USD | 84.485% |
| Cerus Corporation | 197.74 Million USD | 95.059% |
| Envoy Medical, Inc. | 7.64 Million USD | -27.88% |
| electroCore, Inc. | 16.38 Million USD | 40.38% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -27.015% |
| IceCure Medical Ltd | 16.41 Million USD | 40.463% |
| Inogen, Inc. | 326.19 Million USD | 97.005% |
| OrthoPediatrics Corp. | 449.58 Million USD | 97.827% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 64.173% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 41.07% |
| MaxCyte, Inc. | 268.27 Million USD | 96.358% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -20.657% |
| Nexalin Technology, Inc. | 3.63 Million USD | -169.004% |
| Orthofix Medical Inc. | 925.31 Million USD | 98.944% |
| PAVmed Inc | 33.11 Million USD | 70.5% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 93.189% |
| RxSight, Inc. | 182.55 Million USD | 94.648% |
| Sight Sciences, Inc. | 166.65 Million USD | 94.137% |
| SI-BONE, Inc. | 230.42 Million USD | 95.76% |
| TELA Bio, Inc. | 78.04 Million USD | 87.482% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.122% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 8.947% |
| Acutus Medical, Inc. | 53.96 Million USD | 81.894% |
| Talis Biomedical Corporation | 98.34 Million USD | 90.065% |
| Spectral AI, Inc. | 10.69 Million USD | 8.623% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 95.532% |
| CVRx, Inc. | 115.22 Million USD | 91.521% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 83.345% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -213.618% |
| Bioventus Inc. | 810.91 Million USD | 98.795% |
| Venus Concept Inc. | 93.65 Million USD | 89.568% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 62.021% |
| LivaNova PLC | 2.42 Billion USD | 99.598% |
| 908 Devices Inc. | 202.98 Million USD | 95.187% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.787% |
| Nemaura Medical Inc. | 14.56 Million USD | 32.913% |
| NeuroPace, Inc. | 107.65 Million USD | 90.924% |
| LENSAR, Inc. | 69.58 Million USD | 85.96% |
| Apyx Medical Corporation | 79.24 Million USD | 87.67% |
| Cutera, Inc. | 346.29 Million USD | 97.179% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 76.747% |
| BioSig Technologies, Inc. | 1.79 Million USD | -443.382% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.39% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 77.099% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.742% |
| Axonics, Inc. | 719.92 Million USD | 98.643% |
| Outset Medical, Inc. | 313.8 Million USD | 96.887% |
| IRIDEX Corporation | 34.43 Million USD | 71.629% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.586% |
| IRadimed Corporation | 92.15 Million USD | 89.398% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -85.954% |
| INVO Bioscience, Inc. | 20.88 Million USD | 53.226% |
| Telesis Bio, Inc. | 70.41 Million USD | 86.124% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 93.66% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.218% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.051% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4.941% |
| Pulmonx Corporation | 178.95 Million USD | 94.54% |
| Dynatronics Corporation | 25.94 Million USD | 62.337% |
| Modular Medical, Inc. | 13.8 Million USD | 29.239% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 8.921% |
| Semler Scientific, Inc. | 78.06 Million USD | 87.485% |
| InMode Ltd. | 863.28 Million USD | 98.868% |
| Bruker Corporation | 4.24 Billion USD | 99.77% |
| Cytosorbents Corporation | 53.26 Million USD | 81.656% |
| DexCom, Inc. | 6.26 Billion USD | 99.844% |
| Align Technology, Inc. | 6.08 Billion USD | 99.839% |
| Viveve Medical, Inc. | 25.91 Million USD | 62.297% |
| ZimVie Inc. | 1.2 Billion USD | 99.189% |
| Movano Inc. | 9.42 Million USD | -3.704% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.037% |
| Nexalin Technology, Inc. | 3.63 Million USD | -169.004% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 83.345% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 98.974% |
| Profound Medical Corp. | 43.68 Million USD | 77.636% |
| Insulet Corporation | 2.58 Billion USD | 99.623% |
| enVVeno Medical Corporation | 48.63 Million USD | 79.912% |
| Surmodics, Inc. | 185.73 Million USD | 94.74% |
| iCAD, Inc. | 41.41 Million USD | 76.411% |
| Biotricity, Inc. | 5.94 Million USD | -64.405% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 97.744% |
| Aethlon Medical, Inc. | 8.24 Million USD | -18.482% |
| InspireMD, Inc. | 47.64 Million USD | 79.493% |
| PAVmed Inc. | 33.11 Million USD | 70.5% |
| BIOLASE, Inc. | 35.1 Million USD | 72.166% |
| Beyond Air, Inc. | 56.96 Million USD | 82.848% |
| FONAR Corporation | 214.24 Million USD | 95.44% |
| AxoGen, Inc. | 196.82 Million USD | 95.036% |
| Vivani Medical, Inc. | 45.79 Million USD | 78.667% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 96.529% |
| Inari Medical, Inc. | 674.23 Million USD | 98.551% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.582% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 58.245% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -2.808% |
| Tenon Medical, Inc. | 6.34 Million USD | -53.98% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -3.859% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 90.574% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.789% |
| Sintx Technologies, Inc. | 15.36 Million USD | 36.414% |
| NanoVibronix, Inc. | 6.67 Million USD | -46.389% |
| Quanterix Corporation | 425.01 Million USD | 97.701% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -4.941% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 81.815% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.44% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.616% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 84.539% |
| NeuroMetrix, Inc. | 21.42 Million USD | 54.398% |
| Hyperfine, Inc. | 94.19 Million USD | 89.628% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.363% |
| Biomerica, Inc. | 9.25 Million USD | -5.576% |
| Bone Biologics Corporation | 3.73 Million USD | -161.386% |
| AVITA Medical, Inc. | 144.33 Million USD | 93.231% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -100.677% |
| Silk Road Medical, Inc | 265.3 Million USD | 96.318% |